"Methodist Le Bonheur Healthcare in Memphis, TN, in partnership with its medical staffs, will collaborate with patients and their families to be the leader in providing high quality, cost-effective patient-and family-centered care. Services will be provided in a manner which supports the health ministries and Social Principles of The United Methodist Church to benefit the communities we serve."

During the past decade, University of Tennessee Cancer Institute at Methodist Central Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Tennessee Cancer Institute at Methodist Central Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "University of Tennessee Cancer Institute at Methodist Central Hospital" are "Colorectal Cancer" (2 trials), "Bladder Cancer" (1 trials), "Breast Cancer" (1 trials), "Endometrial Cancer" (1 trials) and "Leukemia" (1 trials). Many other conditions were trialed in "University of Tennessee Cancer Institute at Methodist Central Hospital" in a lesser frequency.

Most popular intervention types in "University of Tennessee Cancer Institute at Methodist Central Hospital" are "Drug" (8 trials), "Procedure" (3 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "carboplatin" (2 trials), "paclitaxel" (2 trials), "radiation therapy" (2 trials), "PTK787/ZK 222584" (1 trials) and "adjuvant therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Tennessee Cancer Institute at Methodist Central Hospital" are 5 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Tennessee Cancer Institute at Methodist Central Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in University of Tennessee Cancer Institute at Methodist Central Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Tennessee Cancer Institute at Methodist Central Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".